Dendreon Corporation - DNDN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Dendreon Corporation - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
DNDN	Nasdaq	8731	http://www.dendreon.com/	3.99 -0.09
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Dendreon Corporation An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point - Jun 18th, 2013 9:34 am Where Is Biotechnology's Next 'Anti-PD-1'? - Jun 18th, 2013 5:57 am J&J to Buy Aragon Pharmaceuticals for Cancer Candidate - Jun 17th, 2013 2:54 pm Beware the Bullishness on Bristol-Myers - Jun 16th, 2013 2:05 am One Person's Trash Is Another Person's Treasure Portfolio - Jun 13th, 2013 4:32 pm Analysts: MasterCard Volume Is Growing Faster Than Thought and 3 More Research Notes to Read - Jun 13th, 2013 11:34 am 3 Reasons You Shouldn't Buy Stocks in Biotech - Jun 13th, 2013 8:32 am 5 Names With Sharp Rises In Short Interest - Jun 13th, 2013 12:12 am Largest option buying in equities so far - Jun 12th, 2013 9:22 am When It Comes To Biotech, Diversity Is Key - Jun 12th, 2013 5:51 am A Promising Platform for Cancer Immunotherapy - Jun 8th, 2013 6:02 am SmithOnStocks Opines Week Of June 2, 2013 - Jun 3rd, 2013 5:00 am 4 Healthcare Stock Stories To Close Out the Week - May 31st, 2013 4:25 pm This Cancer Drug Developer Could Really Use a Partner - May 31st, 2013 2:43 pm Toyota’s Cautious Approach to China, Dell Urges Shareholders In Favor of Dell-Silverlake, and 3 More Hot Stocks - May 31st, 2013 11:37 am MARKET PULSE-Omnivision, Palo Alto, Krispy Kreme, Guess, Uroplasty - May 31st, 2013 9:12 am MARKET PULSE-Omnivision, Palo Alto, Sprint, Krispy Kreme, Guess - May 31st, 2013 7:26 am 5 Worst Biotechs of 2013 - May 31st, 2013 6:03 am Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2013 ASCO Annual Meeting - May 31st, 2013 6:00 am One Person's Trash Is Another Person's Treasure Portfolio - May 30th, 2013 5:40 pm View All Current Headlines >>